×
About 5,375 results

ALLMedicine™ Candidiasis Center

Research & Reviews  1,606 results

Ibrexafungerp to treat acute vulvovaginal candidiasis.
https://doi.org/10.1038/s41585-021-00522-9 10.1093/cid/ciab750
Nature Reviews. Urology; Masone MC

Sep 23rd, 2021 - Ibrexafungerp to treat acute vulvovaginal candidiasis.|2021|Masone MC,|

Ibrexafungerp (Brexafemme) for vulvovaginal candidiasis.
https://www.ncbi.nlm.nih.gov/pubmed/34550113
The Medical Letter on Drugs and Therapeutics;

Sep 23rd, 2021 - Ibrexafungerp (Brexafemme) for vulvovaginal candidiasis.|2021||

Mucoadhesive gellan gum hydrogel containing diphenyl diselenide-loaded nanocapsules pre...
https://doi.org/10.1016/j.ejps.2021.106011
European Journal of Pharmaceutical Sciences : Official Jo... Zimmermann ES, Ferreira LM et. al.

Sep 20th, 2021 - The aim of this study was to evaluate the in vitro antifungal action of a diphenyl diselenide-loaded poly(ε-caprolactone) nanocapsules suspension (NC-1) and incorporate it into a gellan gum hydrogel formulation in order to assess its in vivo effic...

Loss of AIRE-Mediated Immune Tolerance and the Skin.
https://doi.org/10.1016/j.jid.2021.04.022
The Journal of Investigative Dermatology; Peterson P, Kisand K et. al.

Sep 19th, 2021 - The core function of the immune response is to distinguish between self and foreign. The multiorgan human autoimmune disease, autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED/autoimmune polyendocrine syndrome type 1) is an ex...

Tailoring thixotropic mixed-lipid nanoconstructs of voriconazole for the management of ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451661
Drug Delivery; Abd-Elsalam WH, Nagy YI et. al.

Sep 15th, 2021 - Vulvovaginal candidiasis is a pervasive gynecological condition among women worldwide due to infection recurrence and resistance to conventional drugs. This calls for a novel formulation of alternative medication and with enhanced efficacy. This s...

see more →

Guidelines  8 results

British HIV Association/British Infection Association guidelines on the management of o...
https://doi.org/10.1111/hiv.12806
HIV Medicine 7 References; Dockrell DH, O’Shea D et. al.

Nov 2nd, 2019 - British HIV Association/British Infection Association guidelines on the management of opportunistic infection in people living with HIV: The clinical management of Candidiasis 2019.|2019|Dockrell DH,O’Shea D,Cartledge JD,Freedman AR,|diagnosis,dru...

Microbiological Laboratory Testing in the Diagnosis of Fungal Infections in Pulmonary a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727169
American Journal of Respiratory and Critical Care Medicine; Hage CA, Carmona EM et. al.

Aug 31st, 2019 - Background: Fungal infections are of increasing incidence and importance in immunocompromised and immunocompetent patients. Timely diagnosis relies on appropriate use of laboratory testing in susceptible patients.Methods: The relevant literature r...

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormyc...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394968
Haematologica Tissot F, Agrawal S et. al.

Dec 25th, 2016 - The European Conference on Infections in Leukemia (ECIL) provides recommendations for diagnostic strategies and prophylactic, pre-emptive or targeted therapy strategies for various types of infection in patients with hematologic malignancies or he...

Managing xerostomia and salivary gland hypofunction: executive summary of a report from...
https://doi.org/10.14219/jada.2014.44
Journal of the American Dental Association (1939); Plemons JM, Al-Hashimi I et. al.

Aug 2nd, 2014 - Xerostomia, also known as "dry mouth," is a common but frequently overlooked condition that is typically associated with salivary gland hypofunction, which is the objective measurement of reduced salivary flow. Patients with dry mouth exhibit symp...

Intra-abdominal candidiasis: the guidelines-forgotten non-candidemic invasive candidiasis.
https://doi.org/10.1007/s00134-013-3134-2
Intensive Care Medicine; Montravers P, Dupont H et. al.

Oct 25th, 2013 - Intra-abdominal candidiasis: the guidelines-forgotten non-candidemic invasive candidiasis.|2013|Montravers P,Dupont H,Eggimann P,|therapeutic use,drug effects,drug therapy,microbiology,drug therapy,microbiology,

see more →

Drugs  380 results see all →

News  156 results

FDA Approves Ibrexafungerp for Vaginal Yeast Infection
https://www.medscape.com/viewarticle/952312

Jun 2nd, 2021 - The US Food and Drug Administration (FDA) has approved ibrexafungerp tablets (Brexafemme) as a 1-day oral therapy for vaginal yeast infections, something 3 out of every 4 women encounter at least once in their life. Ibrexafungerp is the first drug...

Psoriasis Clearance Rates Higher With Bimekizumab vs Secukinumab
https://www.medscape.com/viewarticle/949914

Apr 24th, 2021 - Secukinumab is the latest adult plaque psoriasis treatment to be bested by a newcomer, the interleukin 17A and 17F blocker bimekizumab. Rates of complete clearance were substantially higher with bimekizumab in a phase 3 trial with 743 patients wit...

Vulvovaginitis: A Commonsense Approach
https://www.medscape.com/viewarticle/944773

Feb 12th, 2021 - This transcript has been edited for clarity. Matthew F. Watto, MD: Welcome back to The Curbsiders. I'm Dr Matthew Watto, and I'm joined by my two good friends and board-certified internal medicine physicians, Dr Stuart Brigham and Dr Paul Williams...

Fast Five Quiz: Type 2 Diabetes Mellitus Presentation and Diagnosis
https://reference.medscape.com/viewarticle/922985_3

Jan 30th, 2020 - Polyuria, polydipsia, and polyphagia are clinical signs and symptoms of type 2 DM. Other symptoms of type 2 DM include blurred vision, lower extremity paresthesia, and repeated candidiasis (candida balanitis in male patients). Chest pain and short...

FDA Expands Use of Antifungal Micafungin (Mycamine) to Newborns
https://www.medscape.com/viewarticle/923628

Jan 9th, 2020 - The US Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for use of micafungin sodium (Mycamine, Astellas Pharma Inc) for injection in children younger than 4 months of age. The indication spans candidemia,...

see more →